Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|1|1|45-49

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.1, Iss.1, 2004-01, pp. : 45-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-6 as a therapy target in oral squamous carcinoma

By Culig Zoran  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Thymidine Phosphorylase Inhibitors: Recent Developments and Potential Therapeutic Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1113-1123

Bentham Science Publishers

Access to resources Recommend Favorite

The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL

By Carinci Francesco  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 810-818

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin + capecitabine active in head, neck squamous cell carcinoma

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma

By Guo Wei   Zhang Minghui   Shen Supeng   Guo Yanli   Kuang Gang   Yang Zhibin   Dong Zhiming  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2412-2423

Blackwell Publishing

Access to resources Recommend Favorite